SCHEMBL17070256

SCHEMBL17070256

CCOc1ccc(OC(F)(F)c2ccc(-c3ccc(C4CCCCCC4)cc3)c(F)c2F)c(F)c1F

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 1/20 0.38
APP P05067 1/20 0.38
S1PR1 P21453 2/20 0.36
FFAR4 Q5NUL3 1/20 0.33
HTR2A P28223 3/20 0.32
TSHR P16473 2/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
KDM1A O60341 2/20 0.32
FPR2 P25090 2/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
DGAT1 O75907 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17070252 0.91 CYP3A4 (0.31) CYP3A4CYP2C9APPS1PR1HTR2A
SCHEMBL17070266 0.90 ESR2 (0.34) CYP3A4CYP2C9APP
SCHEMBL17070253 0.89 ESR2 (0.36) CYP3A4CYP2C9APPS1PR1ALDH1A1
SCHEMBL17070251 0.89 S1PR1 (0.41) CYP3A4CYP2C9APPS1PR1FFAR4
SCHEMBL15681366 0.89 CYP3A4 (0.43) CYP3A4CYP2C9APPS1PR1FFAR4
SCHEMBL17070254 0.88 ESR2 (0.35) CYP3A4CYP2C9
SCHEMBL16769035 0.87 CYP3A4 (0.41) CYP3A4CYP2C9APPS1PR1FFAR4
SCHEMBL17070268 0.87 ESR2 (0.34) CYP3A4CYP2C9
SCHEMBL16769036 0.85 KDM1A (0.40) CYP3A4CYP2C9APPS1PR1FFAR4
SCHEMBL22765031 0.81 S1PR1 (0.51) CYP3A4CYP2C9APPS1PR1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9493704-B2 Cycloheptane derivative and preparation method and use thereof SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) 2016-11-15 US disclosed
US-9493704-B2 Cycloheptane derivative and preparation method and use thereof SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) 2016-11-15 US disclosed
US-20150252261-A1 CYCLOHEPTANE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD (CN) 2015-09-10 US disclosed
US-20150252261-A1 CYCLOHEPTANE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD (CN) 2015-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150252261-A1 CYCLOHEPTANE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF DHPS, DHCR24, CCNT1 CYP3A4 1216/4885CYP2C9 1304/4885APP 607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.